<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>27555066</identifier>
<setSpec>1989-7286</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Ronchera, J M</dc:author>
<dc:author>Roca, M</dc:author>
<dc:author>Esteban, J M</dc:author>
<dc:author>Menezo, M</dc:author>
<dc:author>Roca, B</dc:author>
<dc:description xml:lang="en">CASE REPORT Punctate inner choroidopathy (PIC) is a variant of multifocal choroiditis that principally affects young and healthy women. A case of this condition is described in a woman who presented with a scotoma as the main complaint. Four months after the diagnosis of PIC, she developed an exudative neurosensory detachment associated with an active focus of juxtafoveal choroiditis. Finally, with systemic corticosteroids and intravitreal ranibizumab, she made excellent progress. DISCUSSION Intravitreal ranibizumab, associated with systemic corticosteroids, may be an effective treatment for exudative neurosensory detachment complicating PIC.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Antiangiogénicos</dc:subject>
<dc:subject>Choroiditis</dc:subject>
<dc:subject>Retinal detachment</dc:subject>
<dc:subject>Coroiditis</dc:subject>
<dc:subject>Punctate inner choroidopathy</dc:subject>
<dc:subject>Ranibizumab</dc:subject>
<dc:subject>Coroidopatía punctata interna</dc:subject>
<dc:subject>Desprendimiento de retina</dc:subject>
<dc:subject>Angiogenesis inhibitors</dc:subject>
<dc:date>2017 Jul </dc:date>
<dc:title xml:lang="es">Coroidopatía punctata interna complicada con desprendimiento neurosensorial exudativo: respuesta favorable al tratamiento con corticoides y ranibizumab intravítreo.</dc:title>
<dc:title xml:lang="en">Punctate inner choroidopathy complicated with exudative neurosensory detachment: A favourable response to treatment with systemic corticosteroids and intravitreal ranibizumab.</dc:title>
<dc:publisher>Archivos de la Sociedad Espanola de Oftalmologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
